Europe resumes use of J&J COVID-19 vaccine after EMA review
April 21, 2021 -- Rollout of the COVID-19 vaccine from Johnson & Johnson will resume after the European Medicines Agency (EMA) confirmed that the vaccine's overall benefit-risk profile remains positive. Read More
EdiGene raises $62M to expand gene editing technologies
April 21, 2021 -- Biotech company EdiGene has raised $62 million in financing to expand its genome editing technologies and to accelerate drug discovery and therapies. Read More
Agathos Biologics launches as a cell and gene therapy company
April 21, 2021 -- Agathos Biologics has launched as a cell and gene therapy research and development company in Fargo, ND. Read More
Waters taps new executives
April 21, 2021 -- Lab equipment supplier Waters has announced several leadership appointments and retirements. Read More
Nanoform, Aprecia collaborate on nanoparticle-enabled 3D printing
April 21, 2021 -- Nanoform Finland and Aprecia are collaborating in the field of nanoparticle-enabled 3D printing to find synergies that seeks to provide customers and the pharmaceutical industry with new capabilities. Read More
Precision NanoSystems launches T-cell kits for mRNA-lipid nanoparticles
April 21, 2021 -- Precision NanoSystems has launched its GenVoy-ILM T Cell Kit for messenger RNA (mRNA) to enable lipid nanoparticle-based ex vivo gene transfer. Read More
GenScript, Singapore's EDDC partner on antifibrosis antibody development
April 21, 2021 -- GenScript ProBio is collaborating with the Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and development, on an antifibrosis antibody to treat idiopathic pulmonary fibrosis. Read More
Debiopharm launches competition for single dose COVID-19 mRNA vaccine
April 20, 2021 -- Debiopharm has announced a global challenge in an effort to develop a single-dose messenger RNA (mRNA) COVID-19 vaccine. Read More
Evotec begins construction on Toulouse biologics manufacturing facility
April 20, 2021 -- Evotec will soon break ground on its first commercial biologics manufacturing facility in Europe at its Campus Curie in Toulouse, France. Read More
Sorrento reports positive clinical results for COVID-19 stem cell treatment
April 20, 2021 -- Sorrento said that all 10 of the COVID-19 patients receiving its stem cell treatment in a phase IB study were discharged from the intensive care unit within three days after their last infusion. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter